Using a Mobile App to Manage Type 1 Diabetes

How patient-generated health data and patient-reported outcomes affect patient–clinician relationships: A systematic review

“…Thirteen (14.4%) of the 90 publications were included for final qualitative synthesis. [43][44][45][46][47][48][49][50][51][52][53][54][55] None of the included publications were excluded based on MMAT quality ratings. Figure 1 depicts the PRISMA flow diagram which illustrates the number of records identified and included and excluded through the screening process.…”

“…46 One included publication focused on surgical patients, 43 and the remaining 12 publications pertained to medical conditions managed by primary care clinicians. [44][45][46][47][48][49][50][51][52][53][54][55] The publications were published between 2007 and 2017 and conducted in the United States (n = 6), Denmark (n = 1), South Korea (n = 1), Finland (n = 1), Slovakia (n = 1), the United Kingdom (n = 1), Italy (n = 1), and Canada (n = 1). The publications used qualitative (n = 8), [43][44][45]48,50,52,53,55 quantitative (n = 1), 49 or mixed methods (n = 4).…”

“…The publications used qualitative (n = 8), [43][44][45]48,50,52,53,55 quantitative (n = 1), 49 or mixed methods (n = 4). 46,47,51,54 Sample sizes ranged from 2 to 800 patients and from 1 to 21 clinicians. All publications described or documented patients recording PGHD and/or PROs for personal use outside the clinic.…”

“…45,46,48,[52][53][54][55] In six publications, clinicians used PGHD to identify patient treatment or goal barriers. 48,50,51,[53][54][55] PGHD was also utilized by clinicians in six publications to gain a greater understanding of a patient's health between clinic visits. [44][45][46][47]53,55 Patients in three publications could record additional PGHD about the context of their health condition in relation to their daily lives that they would share with their clinicians.…”

Enabling prescription-based health apps

“…Thus far the platform has been used to support patients in two distinct areas of healthcare: i) oncology: development of a safe therapy system for the safe delivery of intravenous chemotherapy and a home monitoring system for monitoring and managing toxicity and improving adherence in patients receiving oral anticancer therapies at home [15] and ii) diabetes: a system consisting of a mobile diary and a web dashboard allowing patients to record disease-related information. This information can then be visualised by diabetologists through a dedicated dashboard while also allowing computation of insulin bolus and provide a rulebased alarm functionality [16]. A number of other studies are also running in the platform (data not yet published).…”